Hepatitis B viral load is the amount of hepatitis B virus (HBV) found in a person’s bloodstream. Hepatitis B is a viral infection that can pass from person to person through bodily fluids. It ...
Three scenarios can occur after spontaneous seroconversion from HBeAg to anti-HBe: Most individuals go into the inactive hepatitis B phase ("inactive carrier"), characterized by normalization of serum ...
1dOpinion
The Journey To Hepatitis B Elimination Through Innovation, Early Testing, And Scientific Discovery
As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...
(RTTNews) - Ionis Pharmaceuticals Inc. (IONS) announced that GSK presented positive results from an interim analysis of the Phase 2b B-Clear clinical study of bepirovirsen (formerly IONIS-HBVRx), an ...
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that it will be presenting new data from its Phase 2 trials evaluating the potential clinical impact that VIR-3434 ...
SAN FRANCISCO, Sept. 18, 2025 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company advancing targeted ...
An ad hoc committee under the auspices of the Institute of Medicine will be convened to complete a two phase study on hepatitis B and C elimination. The IOM will conduct a literature review and ...
NEW YORK and VIENNA, Austria, May 09, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus ...
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced it will be presenting new data from its ongoing Phase 2 SOLSTICE and MARCH trials evaluating the potential ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback